6.230USD-7.70%Mkt Cap: 186.28M USDP/E: —Last update: 2026-05-26
Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company's lead product candidate is Descartes-08, an autologous mRNA chimer…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap186.28M USD
Enterprise Value89.48M USD
Revenue (TTM)1.77M USD
Gross Profit-61.05M USD
Net Income (TTM)-130.30M USD
Revenue/Share0.0680 USD
Last Price6.230 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees75
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.14
PEG—
EV/EBITDA-1.01
EV/Revenue50.41
P/S110.57
P/B-1.38
EPS (TTM)-5.80
EPS (Forward)-2.13
52W Range
5.6006% of range15.57
52W High15.57 USD
52W Low5.600 USD
Profitability
Gross Margin0.00%
Oper. Margin-33973.08%
EBITDA Margin0.00%
Profit Margin-4658.63%
ROE103.22%
ROA-43.96%
Growth
Revenue Growth-92.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-73.94M USD
CapEx (TTM)5.45M USD
FCF Margin-2640.61%
FCF Yield-25.16%
Net Debt-106.79M USD
Net Debt/EBITDA1.20
Balance Sheet
Debt/Equity-0.10
Current Ratio7.65
Quick Ratio7.46
Book Value/Sh-4.8530 USD
Cash/Share4.038 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateApr 5, 2024
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)34.86 USD
Target Range16.00 USD – 44.00 USD
# Analysts7
Ownership
Shares Out.29.38M
Float9.57M
Insiders53.68%
Institutions24.55%
Short Interest
Short Ratio13.1d
Short % Float16.68%
Short % Out.7.38%
Shares Short2.17M
Short (prev mo.)2.17M
Technical
SMA 506.840 (-8.9%)
SMA 2008.032 (-22.4%)
Beta0.56
S&P 52W Chg28.31%
Avg Vol (30d)183.47K
Avg Vol (10d)153.11K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—